USPTO serial 87452085
BI BIOLOGICAL INDUSTRIES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 10, 2018
- Examiner
- WATTS-FITZGERALD, CAITLIN C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
Need help with BI BIOLOGICAL INDUSTRIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Biological Industries Israel Beit Haemek Ltd.
MPO Oshrat, IL
Other trademarks owned by Biological Industries Israel Beit Haemek Ltd.
Biological Industries Israel Beit Haemek Ltd.
MPO Oshrat, IL
Other trademarks owned by Biological Industries Israel Beit Haemek Ltd.
Biological Industries Israel Beit Haemek Ltd.
MPO Oshrat, IL
Other trademarks owned by Biological Industries Israel Beit Haemek Ltd.
SARTORIUS BIOLOGICAL INDUSTRIES LTD
BEIT HAEMEK, IL
Other trademarks owned by SARTORIUS BIOLOGICAL INDUSTRIES LTD
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Megan K. Bowen
Megan K. Bowen Edell, Shapiro & Finnan, LLC9801 Washingtonian Boulevard, Suite 750Gaithersburg, MD 20878United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; [ Mixtures of chemicals and microorganisms for sterilizing compost for use in agriculture; ] Chemical substances, chemical materials and chemical preparations and natural elements all the foregoing being chemicals for use in industry and science; Reagents for scientific or medical research use; Reagents for scientific or medical research use, namely, reagents for use in immunoserology; Diagnostic preparations other than for medical or veterinary purposes; Stem cells for research and scientific purposes; Anti-freezing preparations; Freezing agents for use in freezing biological specimens, namely, cryogenic preparations in solid, liquid or gas state for use in chilling and freezing; Reagents for research purposes, namely, blood grouping reagents other than for medical use; Cell culture media for scientific and research use; Cell culture media for scientific and research use, namely, blood cell culture media for scientific use; [ biological activators for plants; ] Pharmaceuticals, medical and veterinary preparations, namely, biological preparation for use in cell cultures other than for medical or veterinary use | ACTIVE | Apr 28, 2002 |
| 005 | Medical and veterinary preparations and articles, namely, bacterial and bacteriological preparations for medical or veterinary purposes; Diagnostic preparations for medical and veterinary use; Diagnostic preparations for medical or veterinary purposes, Diagnostic agents, preparations and substances for medical purposes; [ Pharmaceuticals and natural remedies, namely, natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Bacteriological culture mediums; serums, namely, medicated hair serums; Pharmaceutical preparations, namely, medicated hair serums; Pharmaceutical preparations for human use, namely, human vaccine preparations; Pharmaceutical preparations for medical purposes, namely, diagnostic preparations for medical purposes; ] Pharmaceutical preparations for activating cellular function; Cellular function activating agents for medical purposes; [ Cellulose esters for pharmaceutical purposes; Medicines for intestinal disorders; Pharmaceutical drugs, namely, drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drugs for medical purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Live organs and tissues for surgical purpose; ] Stem cells for medical purposes; Clinical medical reagents; Cultures of microorganism for medical use; Medical products to support the growth of stem cells, namely, cytostatics for pharmaceutical purposes; [ Surgical implants grown from stem cells in the nature of surgical implants comprised of living tissues; ] Medical diagnostic reagents; Reargents for blood grouping in the nature of reagents for medical use; Blood components, namely, platelet rich blood plasma and stem cells for medical use; Blood plasma [ ; Blood substitutes for human use ] | ACTIVE | Apr 28, 2002 |
| 041 | [ Education services, namely, conducting programs and courses in the field of science and medicine; publication services, namely, publishing of journals, books and handbooks; publication of scientific research, namely, publishing and issuing scientific papers in relation to medical technology; Publication of the results of clinical trials for pharmaceutical preparations; Arranging and conducting educational conferences, courses, trainings, seminars in the field of science and medicine ] | SECTION 8 - CANCELLED | Apr 28, 2002 |
| 042 | [ Scientific and technological services, namely, scientific research and analysis in the field of medicine; research and development services in connection with medicine; Industrial analysis and research services in the field of medicine; scientific and biological services, namely, biological cloning services; natural science services, namely, consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; medical laboratory services; medical and pharmacological research and development services; biological analysis; biological research; clinical research and medical research, namely, basic and clinical research in the field of respiratory science and medicine; biological development, namely, custom design and development of safe chemical and biological agent simulants for use in air quality measurement; Consultancy relating to pharmaceutical research and development, namely, technical consulting in the field of pharmaceutical studies; Research in the field of stem cells; Research and development of vaccines and medicines; Development of pharmaceutical preparations and medicines; Analysis of human serum for medical research; Pharmaceutical drug development services; Provision of information and data relating to medical and veterinary research and development; Testing, authentication and quality control for others in the field of medical and pharmaceutical research; Advisory services relating to material testing, namely, materials testing and analysing; Analysis of human tissues for medical research; Scientific research and development services relating to the isolation and cultivation of human tissues and cells ] | SECTION 8 - CANCELLED | Apr 28, 2002 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Biological Industries Israel Beit Haemek Ltd.
- Other trademarks owned by Biological Industries Israel Beit Haemek Ltd.
- Other trademarks owned by Biological Industries Israel Beit Haemek Ltd.
- Other trademarks owned by SARTORIUS BIOLOGICAL INDUSTRIES LTD
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named BI BIOLOGICAL INDUSTRIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 24, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 9, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 9, 2024 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 5, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 8, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Apr 10, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 10, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 23, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 23, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 3, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 15, 2017 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Dec 8, 2017 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Dec 3, 2017 | ALIE | ASSIGNED TO LIE | — |
| Nov 22, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 21, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 20, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 20, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 7, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| May 22, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 19, 2017 | NWAP | NEW APPLICATION ENTERED | — |